Teva CEO Steps Down. Shlomo Yanai CEO of Teva (TEVA) announced he is stepping down from his position with the company. He will be replaced in May by Jeremy Levin, formerly of Bristol-Myers Squibb. Under the leadership of Yanai, who had no previous pharmaceutical experience, Teva shares declined 22% last year. Pre-market: 41.99 +1.63 (4.04%)
Upgrades
Kirby Corp. (KEX): RBC Capital raised their rating from Outperform to Top Pick and raised their target price from $74.00 to $80.00. Pre-market: 65.84 0.00 (0.00%)
Under Armour (UA): Robert W. Baird raised their rating from Neutral to Outperform and raised their target price from $84.00 to $90.00. Pre-market: 73.46 +1.67 (2.33%)
Potash Corp. of Saskatchewan (POT): Susquehanna raised their rating from Neutral to Positive and raised their target price from $51.00 to $52.00. Pre-market: 42.45 +1.17 (2.83%)
Oshkosh (OSK): JP Morgan raised their rating from Neutral to Overweight. Pre-market: 21.44 +0.06 (0.28%)
Cognizant Tech (CTSH): Nomura raised their rating from Neutral to Buy. Pre-market: 64.31 0.00 (0.00%)
Downgrades
Navistar International (NAV): JP Morgan lowered their rating from Neutral to Underweight. Pre-market: 38.38 +0.50 (1.32%)
Coverage Initiated
Angie's List (ANGI): Oppenheimer initiated coverage with a Perform rating and target price of $16.00.
Markets:
Futures at 7:24: Dow +1.69%. S&P +1.29%. Nasdaq +1.64%. Crude +1.68% to $101.72. Gold +1.49% to $1590.30.
Futures at 7:24: Dow +1.69%. S&P +1.29%. Nasdaq +1.64%. Crude +1.68% to $101.72. Gold +1.49% to $1590.30.
Europe: London +0.98%. Paris -0.71%. Frankfurt +0.81%.
Asia: Japan closed. Hong Kong +2.40% to 18877. China closed. India +2.72% to 15939.
No comments:
Post a Comment